Literature DB >> 32171077

Are three drugs for malaria better than two?

Philip J Rosenthal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32171077     DOI： 10.1016/S0140-6736(20)30560-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  New Acyl Derivatives of 3-Aminofurazanes and Their Antiplasmodial Activities.

Authors:  Theresa Hermann; Patrick Hochegger; Johanna Dolensky; Werner Seebacher; Robert Saf; Marcel Kaiser; Pascal Mäser; Robert Weis
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-27

2.  Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.

Authors:  Kristina Kesely; Panae Noomuna; Michal Vieth; Philip Hipskind; Kasturi Haldar; Antonella Pantaleo; Francesco Turrini; Philip S Low
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

3.  Imatinib augments standard malaria combination therapy without added toxicity.

Authors:  Huynh Dinh Chien; Antonella Pantaleo; Kristina R Kesely; Panae Noomuna; Karson S Putt; Tran Anh Tuan; Philip S Low; Francesco M Turrini
Journal:  J Exp Med       Date:  2021-08-26       Impact factor: 14.307

4.  Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether.

Authors:  Daniel J Watson; Lizahn Laing; Liezl Gibhard; Ho Ning Wong; Richard K Haynes; Lubbe Wiesner
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.